Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Open in API
Filings indexed 918 across all filing types
Latest filing 2005-05-13 Capital/Financing Update
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC, dated May 13, 2005, for Amphastar Pharmaceuticals, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes details about the offering, underwriting, risk factors, business description, management, financial data, and other typical components of a registration statement prospectus. This is not a financial report like an annual or quarterly report, nor is it a call transcript, audit report, or other categories. It is a capital markets filing related to the company's capital raising activities. According to the filing definitions, updates on company fundraising or financing activities fall under Capital/Financing Update (CAP). Therefore, the correct classification is CAP with high confidence.
2005-05-13 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2005-02-22 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated February 11, 2005, for Amphastar Pharmaceuticals, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes details about the offering, underwriting, risk factors, business description, management, and financial data index. This is not a financial report like an annual or quarterly report, nor is it a transcript, audit, or governance document. It is a capital markets filing related to the company's initial public offering and securities registration. According to the filing definitions, updates on company fundraising or financing activities or capital structure changes fall under Capital/Financing Update (CAP). An S-1 registration statement is a primary document for a company's capital raising through public offering. Therefore, the correct classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2005-02-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.